为了防止市场中断, 内部人士持有的指南针治疗股票将被锁定至2025年10月12日. Compass Therapeutics shares held by insiders are locked up until Oct. 12, 2025, to prevent market disruption.

公司高管、董事和某些关联股东持有的 Compass Therapeutics， Inc. 股票须遵守截至 2025 年 10 月 12 日的锁定协议。 Shares of Compass Therapeutics, Inc. held by company officers, directors, and certain affiliated shareholders are subject to a lock-up agreement ending October 12, 2025. 8月12日开始实行的61天限制,禁止在未经Jeffery LLC事先书面同意的情况下出售、提供、认捐、转让或公开宣布处置共同股票、期权、授权令或可兑换证券的计划。 The 61-day restriction, which began August 12, prohibits selling, offering, pledging, transferring, or publicly announcing plans to dispose of common stock, options, warrants, or convertible securities without prior written consent from Jefferies LLC. 该规则适用于直接持有或有利地持有的股份,旨在防止在公开出价后扰乱市场。 The rule applies to shares held directly or beneficially and is designed to prevent market disruption following a public offering. 存在具体例外,但没有详细说明。 Specific exceptions exist but are not detailed.